Immunodominance of poxviral-specific CTL in a human trial of recombinant-modified vaccinia Ankara.

समान संसाधन

• Recombinant modified vaccinia Ankara primes functionally activated CTL specific for a melanoma tumor antigen epitope in melanoma patients with a high risk of disease recurrence.
  द्वारा: Smith, C, और अन्य
  प्रकाशित: (2005)
• Immunodomination during peripheral vaccinia virus infection.
  द्वारा: Leon C W Lin, और अन्य
  प्रकाशित: (2013-01-01)
• Mucosal immunization with PLGA-microencapsulated DNA primes a SIV-specific CTL response revealed by boosting with cognate recombinant modified vaccinia virus Ankara.
  द्वारा: Sharpe, S, और अन्य
  प्रकाशित: (2003)
• Generation of an immunodominant CTL epitope is affected by proteasome subunit composition and stability of the antigenic protein.
  द्वारा: Gileadi, U, और अन्य
  प्रकाशित: (1999)
• Improved Host Range Selection for Recombinant Modified Vaccinia Virus Ankara
  द्वारा: Caroline Staib, और अन्य
  प्रकाशित: (2003-04-01)